XRP price stock watch: Ripple-linked token slides as crypto rally pauses

XRP price stock watch: Ripple-linked token slides as crypto rally pauses

New York, Jan 7, 2026, 10:20 (EST) — Regular session

  • XRP falls about 7% to around $2.21, retreating from a $2.39 24-hour high
  • Traders weigh cooling risk appetite after an early-2026 crypto run
  • Focus turns to ETF flow data and U.S. labor and inflation releases

XRP slipped on Wednesday, down 6.9% over the last 24 hours at about $2.21, after trading as high as $2.39, according to CoinMarketCap data. The token’s market value stood near $134 billion.

The pullback came as a broader crypto rally paused in U.S. morning trade. Bitcoin eased back from a run toward $95,000 earlier this week and XRP fell about 5%, Barron’s reported, pointing to softer tone in tech shares as one drag on risk appetite.

That matters now because XRP had been running hot into the first full trading week of 2026. U.S.-listed spot XRP exchange-traded funds — ETFs, which trade like stocks and give investors exposure without holding the coin — took in about $46 million on Monday and have yet to post a day of net outflows since their mid-November launch, Barron’s wrote, citing CoinGlass and CoinDesk data.

Mainstream finance is also pushing deeper into crypto wrappers. Morgan Stanley filed with the U.S. Securities and Exchange Commission on Tuesday for ETFs tied to bitcoin and solana, and Morningstar ETF analyst Bryan Armour said a bank entering the market “adds legitimacy to it, and others could follow.” Reuters

On the chart, XRP dropped through $2.32 — a “support” level where buyers had previously stepped in — and briefly hit the $2.21 area before demand steadied it, CoinDesk reported. Traders often watch those zones for stop-loss triggers and quick reversals. CoinDesk

But the next push may come from macro, not crypto headlines. The ADP report showed U.S. private payrolls rose by 41,000 in December, below economists’ forecast for a 47,000 increase, and High Frequency Economics chief economist Carl Weinberg called the pace “relatively slow.” Pantheon Macroeconomics chief U.S. economist Samuel Tombs warned ADP’s print “continues to attract more attention than warranted” by its track record. Reuters

For XRP bulls, the near-term question is simple: do ETF inflows keep arriving when the tape turns choppy, or does the market start treating the early-January move as a crowded trade. A decisive break below the low-$2.20s would test that story quickly.

The next hard catalyst is Friday’s U.S. Employment Situation report for December, due at 8:30 a.m. Eastern time, followed by the December CPI release on Jan. 13 and the Federal Reserve’s Jan. 27–28 policy meeting.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong Buy

NVIDIA

94/100
#2 Strong Buy

Meta Platforms

89/100
#3 Buy

Alphabet

87/100
#4 Buy

Amazon

84/100
#5 Selective Buy

Microsoft

80/100
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

Warsh at Jackson Hole

Policy tone can move rates, USD, equities, gold and crypto simultaneously.

#2

Michigan sentiment

A weak final reading or elevated inflation expectations could pressure risk assets.

#3

Chicago PMI

A surprise versus 58.0 may alter the near-term manufacturing-growth narrative.

View full calendar
Times and estimates may change. Verify before trading.
Prudential plc stock slips as $1.2bn buyback kicks off; investors eye March results
Previous Story

Prudential plc stock slips as $1.2bn buyback kicks off; investors eye March results

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next
Next Story

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next